Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$540.7M
+24.8% from 2023
Prescriptions
177K
$3,058.12 per claim
Patients
19K
7,749 prescribers
Total spending, 2024
$541.1M
$27,981.41 per patient
Medicare prescription drug plans paid $540.7M for Dovato in 2024, for 176,818 prescriptions and refills to 19,326 patients (up 24.8% from 2023). The average cost per claim was $3,058.12.
Florida had the highest Medicare cost for Dovato in 2024: $91.3M for 30,453 claims, followed by California ($57.7M).
Juan M Martinez, infectious disease in Tampa, FL, had the highest Medicare cost for Dovato in 2024: 802 claims costing $2.3M.
Dovato is made by GSK plc (GSK), listed in the Medicare spending data as Viiv Healthcare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Juan M Martinez Tampa, FL | Infectious Disease | 802 | 66 | $2.3M |
| Jihad Slim Newark, NJ | Infectious Disease | 798 | 82 | $2.3M |
| Marc A Johnson Charlotte, NC |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5,115 | 106,312 | 12,333 | $309.3M |
| 2023 | 6,509 | 141,331 | 15,924 | $433.3M |
| 2024 | 7,749 | 176,818 | 19,326 | $540.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 685 |
| 77 |
| $2.1M |
| Ruben D Martinez Harlingen, TX | Family Practice | 580 | 87 | $1.7M |
| Gary Blick Norwalk, CT | Infectious Disease | 544 | 55 | $1.6M |
| Federico Hinestrosa Orlando, FL | Infectious Disease | 503 | 54 | $1.6M |
| Roberto Ortiz Orlando, FL | Internal Medicine | 501 | 48 | $1.5M |
| Jose M Pinero Peraza Gainesville, FL | General Practice | 467 | 49 | $1.5M |
| Peter L Alpert Bronx, NY | Infectious Disease | 482 | 49 | $1.4M |
| Jody Borgman Philadelphia, PA | Internal Medicine | 436 | 45 | $1.3M |
| Wilfredo Cuevas San Lorenzo, PR | General Practice | 387 | 45 | $1.2M |
| Larry M Bush Atlantis, FL | Infectious Disease | 412 | 47 | $1.2M |
| William A Duran Caguas, PR | General Practice | 396 | 47 | $1.2M |
| Alireza Farabi Las Vegas, NV | Internal Medicine | 413 | 62 | $1.2M |
| Timothy H Hatcher New Haven, CT | Physician Assistant | 365 | 56 | $1.1M |
| Melissa M Stevenson Albany, GA | Nurse Practitioner | 402 | 53 | $1.1M |
| Warren W Magnus Las Vegas, NV | Family Practice | 375 | 40 | $1.1M |
| Gina Dobbs Birmingham, AL | Nurse Practitioner | 389 | 45 | $1.1M |
| Thomas P Poirier Gainesville, FL | Infectious Disease | 350 | 38 | $1.1M |
| Christina Vu Palm Springs, CA | Internal Medicine | 295 | 39 | $1.1M |
| Sunket Ahkee Boynton Beach, FL | Infectious Disease | 378 | 59 | $1.1M |
| Nelson Vallejo Las Piedras, PR | Internal Medicine | 292 | 38 | $1.1M |
| Lisa Capaldini San Francisco, CA | Internal Medicine | 318 | 40 | $1.0M |
| Deborah L Holmes North Miami Beach, FL | Internal Medicine | 354 | 36 | $1.0M |
| Tanya S Schreibman Sarasota, FL | Infectious Disease | 337 | 39 | $1.0M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Viiv Healthcare GSK | 176,933 | $541.1M |